ClearPoint Neuro, Inc.CLPTNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.5%
5Y CAGR+24.3%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+8.5%/yr
vs +47.4%/yr prior
5Y CAGR
+24.3%/yr
Recent deceleration
Acceleration
-38.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$13.90M+12.1%
2024$12.39M+5.8%
2023$11.71M+7.5%
2022$10.89M+17.4%
2021$9.28M+98.1%
2020$4.69M+66.8%
2019$2.81M+21.6%
2018$2.31M-17.9%
2017$2.81M+7.1%
2016$2.63M-